Dr. Agarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S. MARYLAND
M/C 6038
Chicago, IL 60637Phone+1 773-702-3080
Summary
- Dr. Piyush Agarwal is an urologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from Weill Cornell Medicine and has been in practice 17 years. He also speaks multiple languages, including French, Hindi, and Urdu. He specializes in surgical oncology and is experienced in urologic oncology and bladder cancer. He has more than 100 publications and over 500 citings.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2006 - 2008
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Urology, 2002 - 2006- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 2000 - 2002
Weill Cornell MedicineClass of 2000
Certifications & Licensure
DE State Medical License Current
IL State Medical License 2019 - 2026
IN State Medical License 2023 - 2025
PA State Medical License 2012 - 2021
MD State Medical License 2014 - 2020
VA State Medical License 2018 - 2020
MI State Medical License 2008 - 2015- American Board of Urology Urology
- Join now to see all
Clinical Trials
- Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG Start of enrollment: 2013 Dec 18
- Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) Start of enrollment: 2018 Jun 07
- A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer Start of enrollment: 2022 Mar 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 48 citationsPreexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.David P. Al-Adra, Laura L. Hammel, John P. Roberts, E. Steve Woodle, Deborah Levine
American Journal of Transplantation. 2021-02-01 - 70 citationsPretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.David P. Al-Adra, Laura L. Hammel, John P. Roberts, E. Steve Woodle, Deborah Levine
American Journal of Transplantation. 2021-02-01 - 136 citationsLymph Node Density Is Superior to TNM Nodal Status in Predicting Disease-Specific Survival After Radical Cystectomy for Bladder Cancer: Analysis of Pooled Data From MD...Wassim Kassouf, Piyush K. Agarwal, Harry W. Herr, Mark F. Munsell, Philippe E. Spiess
Journal of Clinical Oncology. 2008-01-01
Press Mentions
What the Color of Your Pee Can Tell You About Your HealthJanuary 30th, 2021- What the Smell of Your Pee Can Tell You About Your HealthJanuary 23rd, 2021
ODAC Cautiously Backs Keytruda in Early Bladder CancerDecember 17th, 2019- Join now to see all
Other Languages
- French, Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
